Pharmaceutical News

RSS

Opinion pieces address Global Vaccine Summit

Project Syndicate last week published two opinion pieces addressing the Global Vaccine Summit, held in Abu Dhabi from April 24-25, which was hosted by His Highness General Sheikh Mohamed bin Zayed bin Sultan Al Nahyan, Crown Prince of Abu Dhabi, in partnership with U.N. Secretary-General Ban Ki-moon and Bill Gates, co-chair of the Bill & Melinda Gates Foundation.

2 May 2013

MSF, GAVI Alliance vaccine discussion shows complications in global health programs

Writing in the American Public Health Association International Health Section's "IH-Blog," Jessica Keralis, IH Communications Committee chair, highlights three recently released advocacy videos by Médecins Sans Frontières discussing child vaccines and a subsequent conversation between MSF and the GAVI Alliance over vaccine pricing.

2 May 2013

Blog examines drug donation programs, Big Pharma's role in public health agenda

"Drug donations, reinvestment of profits in developing countries and a more flexible approach to intellectual property have all signaled a more collaborative approach from industry with the likes of GlaxoSmithKline, Sanofi, Johnson & Johnson and Merck all performing well in the 2012 Access to Medicine Initiative," Adam Robert Green, senior reporter with the Financial Times' "This is Africa," writes in the Royal African Society's "African Arguments" blog.

2 May 2013

Mayo Clinic researchers identify 27 genes that respond differently to rubella vaccine

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population.

2 May 2013

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

A new report shows that the number of emergency department visits involving adverse reactions to the sleep medication zolpidem rose nearly 220 percent from 6,111 visits in 2005 to 19,487 visits in 2010.

2 May 2013

Scientists pursue new therapies as H7N9 flu spreads in China

An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.

2 May 2013

Researchers study how ketamine reduces side effects of ECT in people with severe depression

The largest trial into the use of Electroconvulsive Therapy in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe depression.

2 May 2013

SSRIs associated with increased risk of bleeding, transfusion, readmission and death

Selective serotonin reuptake inhibitors (SSRIs) - among the most widely prescribed antidepressant medications - are associated with increased risk of bleeding, transfusion, hospital readmission and death when taken around the time of surgery, according to an analysis led by researchers at UC San Francisco and Baystate Medical Center in Springfield, Mass.

30 Apr 2013

Study: Biologic response modifying drugs can cause acute liver injury

A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

30 Apr 2013

Somalia launches pentavalent vaccine with support from GAVI, UNICEF, WHO

"Coinciding with World Immunization Week, the Somali government announced on 24 April its intention to vaccinate all children under the age of one with a new five-in-one vaccine, known as a pentavalent vaccine, funded by the GAVI Alliance, with [UNICEF] and the [WHO] as implementing partners," IRIN reports.

30 Apr 2013

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.

30 Apr 2013

Continued work needed in vaccine development

Reflecting on World Immunization Week, April 21-28, Angeline Nanni, director of market access at Aeras, discusses the "remarkable results" of expanded immunization programs in a guest post on the Global Health Technologies Coalition's "Breakthroughs" blog.

30 Apr 2013

Kcentra gets FDA approval for adults with acute major bleeding

The U.S. Food and Drug Administration today approved Kcentra (Prothrombin Complex Concentrate, Human) for the urgent reversal of vitamin K antagonist anticoagulation in adults with acute major bleeding.

30 Apr 2013

Some GOP lawmakers are shifting focus from Medicare to the tax code

House Republican leaders began a series of meetings last week to sell this idea to their rank-and-file members. Also in Capitol Hill news, cancer clinics argue that Congress should have addressed the cuts they took as a result of sequestration before turning to the spending reductions' impact on air travel.

30 Apr 2013

FDA approves Octapharma USA's BLA for octaplex

The U.S. Food and Drug Administration has accepted Octapharma USA's Biological License Application for octaplex.

30 Apr 2013

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Merck & Co., Inc., known as MSD outside the United States and Canada, and Pfizer Inc. today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer's ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.

From Pfizer, Inc. 30 Apr 2013

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.

29 Apr 2013

Absorption Pharmaceuticals to obtain patent for Promescent medication

Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation.

29 Apr 2013

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

Veloxis Pharmaceuticals A/S today announced that it has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union.

29 Apr 2013

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

Oxford BioTherapeutics and Boehringer Ingelheim today announce a new alliance focused on the discovery of novel cancer antibody targets that OBT will identify with the help of its OGAP® discovery platform.

29 Apr 2013

Pharmaceutical News

Opinion pieces address Global Vaccine Summit

MSF, GAVI Alliance vaccine discussion shows complications in global health programs

Blog examines drug donation programs, Big Pharma's role in public health agenda

Mayo Clinic researchers identify 27 genes that respond differently to rubella vaccine

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

Scientists pursue new therapies as H7N9 flu spreads in China

Researchers study how ketamine reduces side effects of ECT in people with severe depression

SSRIs associated with increased risk of bleeding, transfusion, readmission and death

Study: Biologic response modifying drugs can cause acute liver injury

Somalia launches pentavalent vaccine with support from GAVI, UNICEF, WHO

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Continued work needed in vaccine development

Kcentra gets FDA approval for adults with acute major bleeding

Some GOP lawmakers are shifting focus from Medicare to the tax code

FDA approves Octapharma USA's BLA for octaplex

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Absorption Pharmaceuticals to obtain patent for Promescent medication

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News